A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Burroughs Wellcome
- Target Recruit Count
- 18
- Registration Number
- NCT00002141
- Locations
- 🇺🇸
Georgetown Univ Med Ctr, Washington, District of Columbia, United States
🇺🇸Ctr for Phase I Research, Wichita, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath